Search hospitals > Michigan > Detroit
Henry Ford Hospital
Claim this profileDetroit, Michigan 48202
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Brain Tumor
1851 reported clinical trials
105 medical researchers
Summary
Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Brain Tumor and other specialties. Henry Ford Hospital is involved with conducting 1,851 clinical trials across 1,287 conditions. There are 105 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Eleanor M. Walker, and Shirish Gadgeel, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Ding WangHenry Ford Hospital5 years of reported clinical research
Expert in Cancer
Studies Non-Small Cell Lung Cancer
49 reported clinical trials
116 drugs studied
Haythem Y. AliHenry Ford Hospital5 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
38 reported clinical trials
102 drugs studied
Eleanor M. WalkerHenry Ford Hospital2 years of reported clinical research
Studies Cancer
Studies Oral Squamous Cell Carcinoma
18 reported clinical trials
58 drugs studied
Shirish Gadgeel, MDHenry Ford Hospital3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Tumors
17 reported clinical trials
28 drugs studied
Clinical Trials running at Henry Ford Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Cancer
Pancreatic Cancer
Lung Cancer
Urothelial Carcinoma
Deep Vein Thrombosis
Brain Tumor
Lymphoma
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Henry Ford Hospital?
Henry Ford Hospital is a medical facility located in Detroit, Michigan. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Brain Tumor and other specialties. Henry Ford Hospital is involved with conducting 1,851 clinical trials across 1,287 conditions. There are 105 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Eleanor M. Walker, and Shirish Gadgeel, MD.
Where is Henry Ford Hospital located?
Henry Ford Hospital is located at 2799 W Grand Blvd, Detroit, MI 48202. For directions, head east on W. Grand Boulevard, pass the John C. Lodge Freeway and McDonald's, then turn left into the hospital's entrance.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Henry Ford Hospital, contact the Patient Billing and Financial Care Assistance department at (833) 660-1065 or visit their eHealth platform. They provide support for Medicare, Medicaid, Marketplace, Commercial or Employer Group plans, and can guide you to financial assistance programs within and outside of Henry Ford, including grant and privately funded healthcare and drug assistance. For details on the Henry Ford Choice network, contact HAP directly.
What insurance does Henry Ford Hospital accept?
Henry Ford Hospital accepts a wide range of insurance plans, including but not limited to Aetna EPO/POS, Blue Preferred PPO, Community Blue PPO, TRUST, Blue Cross Simply Blue PPO/Healthy Blue Achieve, ChampVA, Choice Care PPO, Humana, Health Alliance Plan (HAP), BCBS of Michigan, Beaumont Employee Health Plan, Blue Care Network, Cigna, Medicare, Medicaid, and Priority HMO and PPO. Patients are advised to contact their insurance carrier for specific plan details and coverage, including copays, to understand their financial responsibility prior to their visit.
What awards or recognition has Henry Ford Hospital received?
Henry Ford Hospital in Detroit, Michigan, is a leading research institution, receiving over $28 million annually for research within the Department of Medicine. Additionally, it secures nearly $100 million in annual grants from the National Institutes of Health and other public sources for education and research.